Low-dose DDAVP in nocturnal enuresis
- PMID: 1582097
- DOI: 10.1177/000992289203100507
Low-dose DDAVP in nocturnal enuresis
Abstract
A five-year experience with the vasopressin analogue desmopressin acetate (DDAVP) for nocturnal enuresis is described in 59 children. The initial starting dose of 5 micrograms at bedtime is lower than that reported in other series. Eighty-one percent of patients required 10 micrograms or less to achieve improvement or resolution of bedwetting.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

